AU6021799A - T-type calcium channel - Google Patents

T-type calcium channel

Info

Publication number
AU6021799A
AU6021799A AU60217/99A AU6021799A AU6021799A AU 6021799 A AU6021799 A AU 6021799A AU 60217/99 A AU60217/99 A AU 60217/99A AU 6021799 A AU6021799 A AU 6021799A AU 6021799 A AU6021799 A AU 6021799A
Authority
AU
Australia
Prior art keywords
calcium channel
type calcium
type
channel
calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60217/99A
Inventor
Ming Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
South Alabama Medical Science Foundation
Original Assignee
University of South Alabama
South Alabama Medical Science Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of South Alabama, South Alabama Medical Science Foundation filed Critical University of South Alabama
Publication of AU6021799A publication Critical patent/AU6021799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU60217/99A 1998-08-26 1999-08-26 T-type calcium channel Abandoned AU6021799A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US9800498P 1998-08-26 1998-08-26
US60098004 1998-08-26
US11739999P 1999-01-27 1999-01-27
US60117399 1999-01-27
PCT/US1999/019675 WO2000015845A1 (en) 1998-08-26 1999-08-26 T-type calcium channel

Publications (1)

Publication Number Publication Date
AU6021799A true AU6021799A (en) 2000-04-03

Family

ID=26793874

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60217/99A Abandoned AU6021799A (en) 1998-08-26 1999-08-26 T-type calcium channel

Country Status (5)

Country Link
EP (1) EP1108068A4 (en)
JP (1) JP2002525077A (en)
AU (1) AU6021799A (en)
CA (1) CA2340586A1 (en)
WO (1) WO2000015845A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001062740A1 (en) * 2000-02-25 2001-08-30 South Alabama Medical Science Foundation Mibefradil analogues and their use
WO2001062741A1 (en) * 2000-02-25 2001-08-30 South Alabama Medical Science Foundation Tetrahydronaphtalene derivatives and their use
US7166603B2 (en) 2003-07-23 2007-01-23 Bristol-Myers Squibb Co. Dihydropyrimidone inhibitors of calcium channel function
US7157461B2 (en) 2003-07-23 2007-01-02 Bristol-Myers Squibb Co. Substituted dihydropyrimidine inhibitors of calcium channel function
US7504431B2 (en) 2004-04-16 2009-03-17 Bristol-Myers Squibb Company Sulfonyl amide inhibitors of calcium channel function
EP1632245A1 (en) * 2004-09-02 2006-03-08 Technische Universität Dresden Medizinische Fakultät Carl Gustav Carus ICA512 couples insulin secretion and gene expression in Beta-cells
WO2009108798A1 (en) 2008-02-29 2009-09-03 Vm Discovery Inc. Method for treating pain syndrome and other disorders
WO2011109262A2 (en) * 2010-03-01 2011-09-09 Tau Therapeutics Llc Cancer diagnosis and imaging

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3257675B2 (en) * 1990-10-12 2002-02-18 マックス−プランク−ゲゼルシャフト ツール フェルデルング デル ビッセンシャフテン エー．ファウ． Modified ribozyme

Also Published As

Publication number Publication date
EP1108068A1 (en) 2001-06-20
EP1108068A4 (en) 2002-12-04
JP2002525077A (en) 2002-08-13
WO2000015845A1 (en) 2000-03-23
CA2340586A1 (en) 2000-03-23
WO2000015845A9 (en) 2001-12-13

Similar Documents

Publication Publication Date Title
AU3485999A (en) Neo-tryptophan
AU1208500A (en) Novel immunoadjuvants
AU1424200A (en) Compounds
AU7698998A (en) Substituted peptidylamine calcium channel blockers
AU1919100A (en) Microporous applicator
AU4501699A (en) Aminoazole compounds
AU2234699A (en) Multiplex vgid
AU1434500A (en) Compounds
AU1705499A (en) Absorbent article having channel
AU3522399A (en) Carvedilol-galenics
AU3437799A (en) City-car
AU6021799A (en) T-type calcium channel
AU5407599A (en) Sphingolipid-desaturase
AU8363398A (en) Capotasto
AUPP157398A0 (en) Water drainage channel
AU1707599A (en) Retinoid-glitazone combinations
AU2609599A (en) Sensor-coupling
AU3204999A (en) Futureball
AU2069199A (en) Codelets
AU2331699A (en) Self-inducting aerator
AU5223199A (en) Bathtub-bathseat
AU1055399A (en) Rollerboard
AUPP326198A0 (en) Hydroponic drainage channel
AU3242199A (en) Variable ratio drive system
AU3347599A (en) Aeromobile

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase